|
|
||||||||
Department of Internal Medicine, Division of Geriatrics, University of Michigan Health System, and the GRECC VA Ann Arbor Healthcare System.
Address correspondence to Cathy C. Lee, MD, VA Ann Arbor Healthcare System, 2215 Fuller Road, GRECC 11-G, Ann Arbor, MI 48105. E-mail: clchopra{at}umich.edu
| Abstract |
|---|
|
|
|---|
Methods. Insulin sensitivity and abdominal adiposity were measured in healthy, nondiabetic older (64 ± 6 years; mean ± standard deviation) men (n = 23) and women (n = 31). Metabolic Insulin Sensitivity Index (SI) was determined from a frequently sampled insulin-assisted intravenous glucose tolerance test. Body fat mass and abdominal fat mass were determined from dual energy X-ray absorptiometry (DXA) scans. Anthropometric measures included waist and hip circumferences, height, and body weight.
Results. Although waist circumference, waist index (waist circumference divided by height), and waisthip ratio (WHR) were all lower in women than in men, there was no sex difference in DXA L1L4 fat mass. In univariate analyses, SI was significantly inversely related with body weight, body mass index, waist circumference, waist index, percentage of total body and abdominal fat, and DXA L1L4 fat mass but not with WHR. The DXA L1L4 fat mass was identified as the best independent predictor of SI, accounting for 41.2% of the variance (p <.0001) in a stepwise multiple regression model that controlled for sex.
Conclusions. WHR is not associated with SI in either men or women. Abdominal adiposity measured by DXA L1L4 fat mass provides a sex-independent predictor of SI in older men and women.
Several methodologic approaches are available to assess the amount and distribution of adipose tissue in humans. Recent criteria for the metabolic syndrome include simple anthropometric measures such as WHR and body mass index (BMI; World Health Organization criteria) and waist circumference (National Centers for Environmental Prediction criteria) (6). Hydrodensitometry has generally been considered the reference standard to determine body composition and total adipose mass, but it does not provide a measure of regional, abdominal adipose tissue distribution. Other techniques include more complex imaging modalities (computerized tomography [CT] scans and magnetic resonance imaging [MRI]). A potential advantage of the imaging methods is the ability to discriminate intra-abdominal from subcutaneous fat, as the metabolic disorders linked to abdominal adiposity are believed to be most directly associated with intra-abdominal visceral fat (4,79). Dual energy X-ray absorptiometry (DXA) is another imaging technique to determine body composition that provides measures of lean, adipose, and bone mineral masses. In addition, regional analysis of DXA scans limited to the abdominal area (specifically the region between the top of the first to the bottom of the fourth lumbar vertebrae, L1L4), has been demonstrated to provide a valid measure of abdominal adiposity in comparison to CT scans (10). Although it is recognized that regional analysis of DXA scans cannot separate intra-abdominal from subcutaneous adiposity, the DXA L1L4 measure of abdominal adiposity has been demonstrated to be associated with insulin resistance (11,12).
To date, the relationship between DXA L1L4 fat mass and other measures of total and abdominal adiposity and measures of insulin sensitivity in older men and women has not been examined. The objective of this study was to test the hypothesis that DXA L1L4 fat mass provides a sex-independent predictor of insulin sensitivity in older humans.
| METHODS |
|---|
|
|
|---|
Individuals being treated with medications (e.g., steroids) that could directly affect glucose metabolism were excluded, and those being treated with antihypertensive medications were tapered from their medications and studied after a minimum of 4 weeks without drug therapy. Studies were performed at the University of Michigan General Clinical Research Center on an outpatient basis beginning at 8 AM after an overnight fast. All participants were instructed not to exercise in the 24 hours prior to their study days.
Measurement of Insulin Sensitivity
Insulin sensitivity was assessed during an insulin-assisted frequently sampled intravenous glucose tolerance test (FSIVGTT) (14). Participants were studied in the supine position. Blood samples were obtained from an indwelling retrograde venous catheter placed in a dorsal hand vein 30 minutes prior to study. Arterialized venous samples were obtained by placing this hand into a warming box heated to 60°C (15). An antecubital intravenous catheter was inserted in the contralateral arm to deliver infusions of glucose and insulin. Three resting blood samples taken immediately prior to glucose administration were collected to determine fasting plasma insulin and glucose levels. A bolus injection of 50% glucose (0.3 g/kg of body weight) was administered as an intravenous push over 30 seconds, followed by blood sampling at 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 27, 30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, and 180 minutes after injection. At 20 minutes, an intravenous bolus of 0.02 U of regular insulin per kilogram of body weight was administered.
Measurements of Body Composition
Total and abdominal body composition were assessed by DXA (Lunar DPX-IQ 240 densitometer, medium collimation, medium speed; Lunar Radiation Corp., Madison, WI) within 2 weeks of the FSIVGTT. Analysis of the total body scan was performed using Extended Research Mode. Quality assurance tests were run every morning using a standard block of tissue-equivalent material. The coefficient of variation (CV) for the DXA is
2.0%.
Anthropometric assessment included measurement of waist (minimum circumference of the waist) and hip (maximum circumference of the buttocks) circumferences. Triplicate circumference measurements of the natural waist (minimum frontal plane diameter and umbilicus) were taken using a Gullick handled woven tape (16). Skin fold thicknesses were measured three times at the suprailiac, suprailium, and abdomen with a Harpenden skin fold caliper following standardized procedures, except for the abdomen skin fold where a vertical rather than horizontal fold was measured (17). The average value of the three trials was used as the criterion value. A single technician performed all of the skin fold and circumference measures.
Participants did not eat, drink, urinate, defecate, or exercise between tests. Participants were clothed in either T-shirt and athletic shorts or a standard hospital gown. Body weight was measured to the nearest 0.1 kg using a medical beam scale. The scale was zeroed before each test and was calibrated on a weekly basis. Height was measured to the nearest 0.5 cm using a stadiometer.
Analytical Methods and Statistical Analysis
Blood samples for plasma glucose and insulin were collected into chilled glass tubes containing sodium heparin, stored on ice, and separated immediately following each study. Plasma was stored at 70°C until assay. Plasma glucose was measured by the autoanalyzer glucose oxidase method, and plasma insulin by double antibody radioimmunoassay (coefficient of variation = 5%) in the Core Laboratory of the University of Michigan Diabetes Research and Training Center. All samples from a given participant were analyzed in the same assay run.
The Insulin Sensitivity Index (SI) was calculated from a least-squares fitting of the temporal pattern of glucose and insulin throughout the FSIVGTT using the MINMOD program (Copyright R. N. Bergman, 1986) (14). SI is a measure of the effect of an increment in plasma insulin to enhance the fractional disappearance of glucose. Area under the curve for glucose and insulin values during the oral glucose tolerance tests were calculated using the trapezoid rule in GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, CA).
Analysis of DXA scans used Lunar software version 4.5c (extended research analysis). The percentage of total body fat was determined from the total fat mass divided by the body weight. The DXA measure of abdominal adiposity (DXA L1L4) was determined with the manual analysis component of the Lunar software package. A rectangle was drawn on the digital scan image bounded superiorly by the horizontal line identifying the T12/L1 intervertebral space, inferiorly by the horizontal line denoting the L4/L5 intervertebral space, and bilaterally by connecting the two horizontal lines in a region free of tissue. Abdominal adiposity, DXA L1L4, was measured as the fat mass within this region. The percentage of abdominal adiposity was determined from the DXA L1L4 fat mass divided by total body fat mass. Prior work from our research group has shown this approach to have good interrater reliability, reproducibility, and validity in comparison to multislice CT scans (18). Additional calculated measures of body composition included BMI (weight divided by height squared), WHR (waist circumference divided by hip circumference), and waist index (waist circumference divided by height).
Sex differences in participant characteristics, glucose and insulin levels, SI, and measures of body composition were evaluated using t tests. The relationships between SI and body composition measures were assessed by multiple regression analysis that included a sex factor. A stepwise multiple regression model was developed to determine which body composition variables were independent predictors of SI among the participants; this model incorporated a forced sex variable.
Data analysis was conducted using StatView (version 5.0; SAS Institute, Chapel Hill, NC), SAS version 6.12 (SAS Institute, Inc., Cary, NC), and GraphPad Prism version 3.00 for Windows (GraphPad Software). A Bonferroni correction was used to account for the four major hypotheses tested so that a level of p
.01 was used to indicate statistical significance. Data are expressed as means ± standard error.
| RESULTS |
|---|
|
|
|---|
|
.01). The strongest univariate relationship with SI was the DXA L1L4 mass. As expected, there were significant positive correlations noted between the majority of the anthropometric and body composition measures. However, percentage of body fat was not significantly related to waist circumference, weight, or percentage of abdominal fat. There was no significant relationship found between SI and age.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
A number of studies (8,9,11,12,1930) have identified that various measures of total and abdominal (or upper body) adiposity are related to insulin sensitivity in older participant populations. Prior to the availability of imaging modalities, WHR was commonly used to reflect the extent of abdominal adiposity (1). However, among the anthropometric indices of abdominal adiposity, measures of waist circumference (3032) or waist index (33) have been found to be better predictors of insulin sensitivity. These findings are consistent with the observation that waist index was closely related to intra-abdominal fat area determined from CT scans in both men and women (33). In the current study, no significant relationship was identified between WHR and insulin sensitivity, whereas SI was negatively related to both waist circumference and waist index.
Although there is an age-related increase in WHR in men and women, WHR remains lower in women suggesting that older women have less abdominal adiposity than do older men (1). Among the studies that included men and women to relate adiposity to insulin sensitivity (8,22,28,30,31), only the study by Cefalu and colleagues (8) incorporated an analysis of the effect of sex on the relationship between the amount and distribution of adiposity and insulin sensitivity. The focus of their study was to isolate the effects of aging from that of visceral abdominal adiposity determined from cross-sectional fat area by CT scan to the SI from an FSIVGTT. Accordingly, the study population included a wider age range (2383 years). Among this population, the independent predictors of SI were intra-abdominal fat and WHR; there were no significant effects noted for age or sex after these two measures were included in a regression model. However, given that there were only three male participants over the age of 60 years in their sample, it is likely that the age and sex distribution of this participant population was not optimal to detect an effect of sex on the relationship between SI and intra-abdominal adiposity among older individuals. The participant populations for other studies that have addressed this relationship include only males (11,20,2426,29) or only females (9,12,19,21,23,27). Thus, the present report is the first to specifically examine the influence of sex on the relationship between measures of total and abdominal adiposity derived from regional analysis of DXA scans and insulin sensitivity in older humans.
The results from the current study suggest that older men and women have similar levels of abdominal fat mass measured from regional analysis of DXA scans. The results from several other studies that have used either CT- or MRI-derived measures of intra-abdominal adiposity conducted in younger participant samples have shown that there is no sex difference in intra-abdominal fat area, but that subcutaneous abdominal fat area is greater in women than in men (8,22,28,30). Because the DXA measure of abdominal fat mass cannot discriminate between subcutaneous and visceral fat, additional studies using a measure of total abdominal adipose volume (subdivided by intra-abdominal and subcutaneous) will be required to confirm the lack of sex difference in intra-abdominal adiposity among older healthy participants suggested from the DXA L1L4 fat mass results.
Previous studies (10,18) have been performed to validate the use of DXA L1L4 fat mass to represent abdominal adiposity as determined from three-dimensional imaging modalities. Our study was not designed to directly compare the relative strength of the relationship between insulin sensitivity and the DXA-derived measure of abdominal adiposity to that obtained from one of the three-dimensional imaging systems. A frequently cited limitation of the two-dimensional DXA regional analysis of abdominal adiposity in comparison to the CT- or MRI-derived abdominal fat areas is its inability to separate intra-abdominal from subcutaneous adiposity. Despite this potential limitation, in this participant population the DXA L1L4 fat mass proved to be a significant, sex-independent predictor of insulin sensitivity. Indeed, there remains some degree of debate concerning which component of abdominal fat (intra-abdominal or subcutaneous) confers the stronger association with adverse metabolic risk factors, including insulin sensitivity. Although the general observation is that intra-abdominal fat mass is the more important component in this respect (8,34,35), some reports have demonstrated that subcutaneous abdominal fat is a unique and independent predictor of insulin sensitivity (22,23,28,29).
We acknowledge several potential limitations inherent in our study. First, we recognize that using DXA to measure body composition and central obesity does not differentiate between subcutaneous and visceral fat. Second, we did not measure other variables in all participants such as aerobic capacity or blood pressure that are known to be associated with insulin resistance. Therefore, we are unable to estimate the variance in SI that might be explained by these other measures relative to the contribution of abdominal adiposity.
Conclusion
Compared to WHR, waist circumference, or waist index, the DXA L1L4 fat mass is the best sex-independent predictor of insulin sensitivity in an older, nondiabetic population. In addition, abdominal adiposity as measured by the DXA L1L4 fat mass was found to be similar in older men and women. Therefore, the other methods of measuring abdominal adiposity (WHR and waist circumference) significantly underestimate the degree of abdominal adiposity in older women.
| Acknowledgments |
|---|
We thank Becky Olson, Amy Woznick, and Marla Smith for their technical assistance and Andrzej Galecki, MD, PhD for his statistical advice.
Portions of this work were presented at the Central Society for Clinical Research and the American Geriatrics Society national meeting in 1997.
| Footnotes |
|---|
Received December 24, 2003
Accepted April 13, 2004
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| All GSA journals | The Gerontologist |
| Journals of Gerontology Series B: Psychological Sciences and Social Sciences | |